Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2023-06-01
2024-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Acute Kidney Injury in Children at Sohag University Hospital
NCT05297214
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
NCT05068167
Acute Kidney Injury as a Risk Factor for Myocardial Injury and Ventricular Dysfunction
NCT04768751
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions
NCT04505891
A Study of Acute Kidney Injury in Care Transitions
NCT05184894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data concerning the spectrum of acute kidney injury (AKI) in Egypt are generally scarce.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AKI group
patients who are hospitalized and develop acute kidney injury after 48 hours from admission
standard AKI care bundle
AKI care bundle include use of iv fluids, diuretics, antihyperkalemic drugs, sodium bicarbonate, antibiotics in septic patients.
no AKI group
patients who are hospitalized and do not develop acute kidney injury after 48 hours from admission till discharge
standard care for hospitalized patients
this includes iv fluids, diuretics, antibiotics in septic patients, other measures according to original disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard AKI care bundle
AKI care bundle include use of iv fluids, diuretics, antihyperkalemic drugs, sodium bicarbonate, antibiotics in septic patients.
standard care for hospitalized patients
this includes iv fluids, diuretics, antibiotics in septic patients, other measures according to original disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age more than 18 years.
Exclusion Criteria
2. Patients who developed acute kidney injury within 48 hours of admission to hospital.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Mamdouh Mahmoud Mohamed Elsayed , MD
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hala S ElWakil, MD
Role: PRINCIPAL_INVESTIGATOR
professor
yasmine s naga, MD
Role: STUDY_CHAIR
ASS. prof
Mohamed mamdouh Elsayed, MD
Role: STUDY_CHAIR
Lecturer
sara R Nagib, MBBCh
Role: STUDY_CHAIR
Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Aexandria University
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Singh TB, Rathore SS, Choudhury TA, Shukla VK, Singh DK, Prakash J. Hospital-acquired acute kidney injury in medical, surgical, and intensive care unit: A comparative study. Indian J Nephrol. 2013 Jan;23(1):24-9. doi: 10.4103/0971-4065.107192.
Sawhney S, Mitchell M, Marks A, Fluck N, Black C. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open. 2015 Jan 6;5(1):e006497. doi: 10.1136/bmjopen-2014-006497.
Hsu CN, Lee CT, Su CH, Wang YL, Chen HL, Chuang JH, Tain YL. Incidence, Outcomes, and Risk Factors of Community-Acquired and Hospital-Acquired Acute Kidney Injury: A Retrospective Cohort Study. Medicine (Baltimore). 2016 May;95(19):e3674. doi: 10.1097/MD.0000000000003674.
Ponce D, Balbi A. Acute kidney injury: risk factors and management challenges in developing countries. Int J Nephrol Renovasc Dis. 2016 Aug 22;9:193-200. doi: 10.2147/IJNRD.S104209. eCollection 2016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hospiat Acq. AKI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.